Log on / register
Feedback | Support | My details
Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer 2007, 6:25
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI
PLoS One 2008, 3:e3661
[PubMed Central] [PubMed] [Related articles]

2.
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
Boccalatte FE, Voena C, Riganti C, Bosia A, D'Amico L, Riera L, Cheng M, Ruggeri B, Jensen ON, Goss VL, Lee K, Nardone J, Rush J, Polakiewicz RD, Comb MJ, Chiarle R, Inghirami G
Blood 2009 Mar 19, 113:2776-90
[PubMed Central] [PubMed] [Related articles]

3.
The role of proteomics in defining the human embryonic secretome.
Katz-Jaffe MG, McReynolds S, Gardner DK, Schoolcraft WB
Mol Hum Reprod 2009 May, 15:271-7
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 5 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.